| n (%) / median [IQR] | ||
|---|---|---|
| Age (years) | 80 [77-85] | |
| Age group (years) | 75-79 | 26,244 (44.4) |
| 80-89 | 27,722 (46.9) | |
| ≥90 | 5,167 (8.7) | |
| Sex | Female | 34,652 (58.6) |
| LTC needs levels | Independent | 41,310 (69.9) |
| Support level 1 or 2 | 6,331 (10.7) | |
| Care level 1 or 2 | 7,653 (12.9) | |
| Care levels 3 to 5 | 3,839 (6.5) | |
| Physical disabilitya | Independent | 41,317 (69.9) |
| Independent living (rank J) | 6,223 (10.5) | |
| Semi-bedridden/bedridden (rank A, B, or C) | 11,593 (19.6) | |
| Cognitive impairmentb | Independent | 43,328 (73.3) |
| Mild/moderate (rank I or II) | 13,335 (22.6) | |
| Severe (rank III, IV, or M) | 2,470 (4.2) |
| n | N | % | aOR (95% CI) | p-Value | |
|---|---|---|---|---|---|
| LTC needs levels | |||||
| Independent | 65 | 41,310 | 0.16 | Reference | Reference |
| Support level 1 or 2 | 30 | 6,331 | 0.47 | 2.68 (1.70-4.21) | <0.001 |
| Care level 1 or 2 | 26 | 7,653 | 0.34 | 1.91 (1.18-3.10) | 0.009 |
| Care levels 3 to 5 | <10 | 3,839 | 1.29 (0.62-2.68) | 0.497 | |
| Hosmer-Lemeshow χ2 (df = 5) | 2.13 | 0.831 | |||
| Disability levels (physical disabilitya and cognitive impairmentb) | |||||
| Independent and independent | 65 | 41,313 | 0.16 | Reference | Reference |
| Independent and mild/moderate | <10 | <10 | - | - | |
| Independent and severe | <10 | <10 | - | - | |
| Independent living and independent | <10 | 1,270 | 1.82 (0.66-5.03) | 0.248 | |
| Independent living and mild/moderate | 28 | 4,895 | 0.57 | 3.24 (2.04-5.15) | <0.001 |
| Independent living and severe | <10 | 58 | - | - | |
| Semi-bedridden/bedridden and independent | <10 | 745 | 1.57 (0.38-6.46) | 0.530 | |
| Semi-bedridden/bedridden and mild/moderate | 24 | 8,437 | 0.28 | 1.58 (0.96-2.61) | 0.075 |
| Semi-bedridden/bedridden and severe | <10 | 2,411 | 1.57 (0.70-3.54) | 0.277 | |
| Hosmer-Lemeshow χ2 (df = 6) | 2.17 | 0.903 | |||
| ICD-10 | Diseases | Prescribed (N = 130) |
Not prescribed (N = 59,003) |
|---|---|---|---|
| n (%) | n (%) | ||
| R63 | Symptoms and signs concerning food and fluid intake | 57 (43.8) | 1,889 (3.2) |
| R53 | Malaise and fatigue | 33 (25.4) | 669 (1.1) |
| M54 | Dorsalgia | 59 (45.4) | 17,010 (28.8) |
| K59 | Other functional intestinal disorders | 69 (53.1) | 22,418 (38.0) |
| M81 | Osteoporosis without pathological fracture | 56 (43.1) | 16,642 (28.2) |
| M47 | Spondylosis | 45 (34.6) | 12,419 (21.0) |
| K29 | Gastritis and duodenitis | 67 (51.5) | 22,650 (38.4) |
| I50 | Heart failure | 44 (33.8) | 12,377 (21.0) |
| J30 | Vasomotor and allergic rhinitis | 47 (36.2) | 13,826 (23.4) |
| G47 | Sleep disorders | 56 (43.1) | 18,134 (30.7) |